Photo: Ariel Skelley/Blend Images/GettyImages
Consumer electronics giant Samsung Electronics announced that it has concluded its acquisition of Xealth, a digital health prescription platform that helps doctors prescribe digital health apps. Samsung signed an agreement to acquire Xealth back in July.
Xealth will continue its operations under its existing brand, and its leadership team will remain in place.
Xealth integrates digital health offerings into the clinical workflow, allowing health systems to improve patient care and drive clinical efficiency.
According to the company, the offerings include multimedia patient education, digital clinical assessments, remote patient monitoring programs, virtual care referrals and other ancillary services that help prepare, assess and support patients before, during and between appointments.
Xealth's Digital Care SMART on FHIR app allows physicians and care teams to order, deliver and monitor digital health tools from the EHR, with clinical decision support that matches patients to pertinent answers.
The app can be downloaded from the EHR’s app stores and configured by the health system team to launch directly in the provider’s charting workflow.
According to the company, the integration provides Xealth the ability to leverage data in the EHR to suggest and automatically enroll patients into various programs.
"Samsung and the Xealth team will engage, learn and support health systems, consumers and digital health partners in creating a healthcare ecosystem that aims to improve the health of everyone," Dr. Hon Pak, senior vice president and head of digital health team, mobile eXperience business of Samsung Electronics, said in a statement.
Mike McSherry, CEO and cofounder of Xealth, asserted that the company's mission is to reinforce the bond between medical care teams and their patients through familiar technologies.
"That driving force is supported and propelled through Samsung in a way that will bring truly connected care and add fresh context to the patient experience in a way not possible before," McSherry said in a statement.
"Together with Samsung and our network of healthcare leaders, we will design a bridge between home health monitoring and clinical decision-making, with provider workflows and the patient-provider relationship at the core."
THE LARGER TREND
In 2024, South Korean-based medical AI provider Lunit signed a three-year supply contract with Samsung Electronics.
The deal was for the integration of Lunit's two chest X-ray AI solutions, Lunit INSIGHT CXR and Lunit INSIGHT CXR Triage, into Samsung's line of premium X-ray devices.
The AI-integrated X-ray devices were initially rolled out in the United States, Canada and Europe.
In 2021, AI developer VUNO closed a deal with Samsung Electronics to incorporate its AI-enabled chest X-ray diagnostic solution with Samsung's premium mobile digital radiograph system.
VUNO's Med Chest X-ray, which was added to Samsung's mobile digital radiograph system, was also integrated into its GC85A premium ceiling type digital radiography system
The deal allowed Samsung Electronics to provide an advanced system that integrates AI technology into its key premium X-ray devices.
In March, Xealth announced a strategic investment from Morningside Ventures.
The funding was used to boost Morningside’s digital health portfolio and expand Xealth’s footprint within health systems by helping them to manage and deploy their digital health formularies more effectively.
In 2024, Xealth announced that the Froedtert & The Medical College of Wisconsin (MCW) health network leveraged its digital health platform to engage select patient populations with Season Health, a clinical nutrition provider.
Via Xealth’s digital health platform, the Froedtert & MCW offered Season Health’s scalable, clinically driven nutrition services to employee and patient populations, with a focus on patients with diabetes. The collaboration aims to improve clinical outcomes by integrating nutrition as a crucial element of chronic condition care.
